Diabetes is notorious for causing trouble in the blood vessels, and the root of this problem is damage to the endothelial cells that line these vessels. Scientists have been curious about a substance called apelin, which seems to have a positive effect on the heart and blood vessels. The big question is, how does apelin work its magic?

Researchers decided to dive deep into this mystery. They used a fancy method called network pharmacology to find common targets between diabetes and apelin. Guess what they found? A pathway called Src/Stat3. This pathway is like a secret tunnel that apelin might use to fix damaged endothelial cells.

To test this idea, scientists created a mini lab environment. They took human umbilical vein endothelial cells (HUVECs) and exposed them to high glucose and oleic acid. This mimics the harsh conditions that these cells face in a diabetic body. Then, they introduced apelin to see what happens.

Here's what they found: Apelin boosted cell survival and movement. It also cut down on cell death and the release of a substance called lactic dehydrogenase (LDH), which is a sign of cell damage. But that's not all. Apelin also increased the activity of some important proteins, including phosphorylated Src, Stat3, and eNOS. These proteins are like little workers that help keep the cells healthy.

So, what does all this mean? Apelin seems to protect and repair endothelial cells by activating the Src/Stat3 pathway and boosting eNOS. This could be a game-changer for developing new drugs to treat heart and blood vessel problems caused by diabetes. But remember, this is just one piece of the puzzle. More research is needed to fully understand how apelin works and how it can be used to help people with diabetes.

Apelin: The Unsung Hero for Blood Vessel Health

Actions